Dr. Shruti Bhat- Leader Pharmaceutical R&D.
Click image to view
Some Endorsements:
"Working with Shruti is always fun. We are extremely satisfied with her work, especially the leadership directives and methodologies employed by her to the team in order to complete the entire new product development portfolio and dossier submission in a such a short time is incredible. We look forward to working with again..."
Cees T. IDA, Netherlands.
"Shruti has impeccable professional character. A team player, she builds instant rapport with her colleagues. She goes an extra mile to get the job done. Her efforts with timely launches of new products and her dedication to her work are noteworthy. I shall be happy to work with her again..."
Makarand Deshapande, Senior Director International sales and marketing, Pharmascience, Canada.
Global Pharmaceutical Industry Trends:
www.drugsinthemaking.com
Leading pharmaceutical Industry news...
New "Smart Bomb" technology invented to target cancer cells.
http://www.pharm-education.com/2010/07/new-smart-bomb-tech-used-to-target.html
Big pharma kisses its blockbuster years goodbye.
http://www.pharmaceuticalpatentsandintellectualproperty.com/2010/12/big-pharma-kisses-its-blockbuster-years.html
New "Smart Bomb" technology invented to target cancer cells.
http://www.pharm-education.com/2010/07/new-smart-bomb-tech-used-to-target.html
Big pharma kisses its blockbuster years goodbye.
http://www.pharmaceuticalpatentsandintellectualproperty.com/2010/12/big-pharma-kisses-its-blockbuster-years.html
Free Newsletter on current Pharmaceutical Research and Technology.
WHITE PAPER
How to develop stable generic Lipitor tablets ?
Is developing generic (Sildenafil) Viagra tablets difficult?
How to BCS classify drugs?
How to develop cost effective generics ?
How to prevent losses during tech transfer ?
What is Quality-by-Design?
Many more...
For FREE whitepaper ,case studies-
Check out :
PRESS ROOM
PRODUCT GALLERY
TOP INNOVATIONS
TECHNOLOGIES
ASK EXPERT
QUALITY-BY-DESIGN
NANOTECHNOLOGY
PATENTS EXPERT
FORMULATIONS
BLOGS
About Dr. Shruti Bhat:
Dr. Shruti Bhat is popularly addressed as “STAR Formulator and ACE Leader”. Shruti, Translates Innovative concepts to profits, consistently !
Shruti is the inventor of generic versions of TOP SELLING brands such as Valtrex, Viagra, Lipitor, Zyrtec, Cefolac, Forecox, Omnacortil, Neurontin, Plavix, Zyban, Prilosec, Zoloft, Prozac, Claritin, Augmenetin, Glucophage and many more ...
Shruti is a Generics and Specialty Pharmaceutical Formulation Development and Pre-formulation Expert, leading international product development R&D and operations for over 14 years and a consultant to several growing pharmaceutical companies worldwide. She is particularly well-known for her contributions within Pharmaceutical R&Ds in Canada, US, Europe and India.
Shruti has extensive experience with identification, development, manufacturing, patenting, registration and commercialization for both generic and brand formulations in Pharmaceuticals, Consumer health care (FMCG) products, Cosmetics, Biotechnology, Herbal and Food sectors.
She has 1500+ product registrations in over 65 countries world-wide, including US, Canada, EU, LATAM and ROW markets, with several first-to-file success highlights.
Building and expanding R&D division from its infancy to $30M market leader in three years is just one of her commendable achievements. Her extensive experience in leading pharma research and operations, have allowed her to achieve remarkable results in decreasing product development timelines by 35%, cycle time reduction by 22 %, lowering operations costs by 17% and increasing total productivity by 200%. Shruti delivers results- every time, through her insightful understanding of corporate goals, outstanding competencies coupled with her EXCLUSIVE TECHNIQUE of applying leading edge solutions in practical and powerful ways.
More about Dr. Shruti Bhat ...
Dr. Shruti Bhat is popularly addressed as “STAR Formulator and ACE Leader”. Shruti, Translates Innovative concepts to profits, consistently !
Shruti is the inventor of generic versions of TOP SELLING brands such as Valtrex, Viagra, Lipitor, Zyrtec, Cefolac, Forecox, Omnacortil, Neurontin, Plavix, Zyban, Prilosec, Zoloft, Prozac, Claritin, Augmenetin, Glucophage and many more ...
Shruti is a Generics and Specialty Pharmaceutical Formulation Development and Pre-formulation Expert, leading international product development R&D and operations for over 14 years and a consultant to several growing pharmaceutical companies worldwide. She is particularly well-known for her contributions within Pharmaceutical R&Ds in Canada, US, Europe and India.
Shruti has extensive experience with identification, development, manufacturing, patenting, registration and commercialization for both generic and brand formulations in Pharmaceuticals, Consumer health care (FMCG) products, Cosmetics, Biotechnology, Herbal and Food sectors.
She has 1500+ product registrations in over 65 countries world-wide, including US, Canada, EU, LATAM and ROW markets, with several first-to-file success highlights.
Building and expanding R&D division from its infancy to $30M market leader in three years is just one of her commendable achievements. Her extensive experience in leading pharma research and operations, have allowed her to achieve remarkable results in decreasing product development timelines by 35%, cycle time reduction by 22 %, lowering operations costs by 17% and increasing total productivity by 200%. Shruti delivers results- every time, through her insightful understanding of corporate goals, outstanding competencies coupled with her EXCLUSIVE TECHNIQUE of applying leading edge solutions in practical and powerful ways.
More about Dr. Shruti Bhat ...
CONSULTING ...
Disclaimer : The website and blog information, videos and other associated published content is the sole property of Dr.Shruti Bhat, not to be copied, distributed or used without prior authorization by the owner.
Keywords- Pharmaceutical, product, research, development (R&D), OTC, biotech, new drug application, patents, application, market approval, new drug application, licensing, reliability, process control, senior, leadership, successful, executive, management, brand, branding, published, FDA, audits, QA, TPD, Health Canada, GMP, cGMP, HPB, MHRA, WHO, ICH, HPFBI, TGA, Anvisa, CAPA, ARP, QC, analysis, bio similars, biological, generics, innovation, inventive, vice president, director, scale up, trouble shooting, manufacturing, operations, life science, scientist, dosage form, NDDS, mucosal, delivery, systems, specialty, filing, experience, NDA, IND, ANDA, ANDS, 505 B2, regulatory, CMC, submission, tech transfer, pre formulation, post market surveillance, medical device, compliance, product development, novel, contract, US, India, medical review board, subject matter expert, SME, expert, specialist, health care. Keywords- Pharmaceutical, product, research, development (R&D), OTC, biotech, new drug application, patents, application, market approval, new drug application, licensing, reliability, process control, senior, leadership, successful, executive, management, brand, branding, published, FDA, audits, QA, TPD, Health Canada, GMP, cGMP, HPB, MHRA, WHO, ICH, HPFBI, TGA, Anvisa, CAPA, ARP, QC, analysis, bio similars, biological, generics, innovation, inventive, vice president, director, scale up, trouble shooting, manufacturing, operations, life science, scientist, dosage form, NDDS, mucosal, delivery, systems, specialty, filing, experience, NDA, IND, ANDA, ANDS, 505 B2, regulatory, CMC, submission, tech transfer, pre formulation, post market surveillance, medical device, compliance, product development, novel, contract, US, India, medical review board, subject matter expert, SME, expert, specialist, health care.
